From: Risk environments facing potential users of a supervised injection site in Ottawa, Canada
 | Intention to use an SIS in Ottawa; no. (and %) of participantb |  | |
---|---|---|---|
Characteristicc | Yes | No | OR (and 95Â %CI)d |
n = 205 | n = 67 | ||
Age | 42.0 | 44.0 | p value = 0.04 |
Sexual identity | Â | Â | Â |
 LGBTQ | 29 (93.5) | 2 (6.5) | 5.61 (1.30–24.19) |
 Straight | 168 (72.1) | 65 (27.9) |  |
Injects with other people | Â | Â | Â |
 Yes | 176 (80.0) | 44 (20.0) | 3.23 (1.66–6.27) |
 No | 26 (55.3) | 21 (44.7) |  |
Injects in public | Â | Â | Â |
 Yes | 81 (82.7) | 17 (17.3) | 1.98 (1.06–3.70) |
 No | 113 (70.6) | 47 (29.4) |  |
Assistance to inject | Â | Â | Â |
 Yes | 81 (81.8) | 18 (18.2) | 1.84 (1.00–3.38) |
 No | 120 (71.0) | 49 (29.0) |  |
Last hep C test | Â | Â | Â |
 Positive | 129 (80.1) | 32 (19.9) | 2.13 (1.16–3.91) |
 Negative | 51 (65.4) | 27 (34.6) |  |
Overdosed | Â | Â | Â |
 Yes | 66 (83.5) | 13 (16.5) | 2.00 (1.02–3.92) |
 No | 137 (71.7) | 54 (28.3) |  |